MUC5AC and metabolic dysfunction-associated steatotic liver disease: Initially discovered for its mucin-degrading capabilities, AM has now been linked with multiple metabolic diseases, including obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) — now more accurately described as metabolic dysfunction-associated steatotic liver disease (MASLD) [2].